Home » Topics » Conferences

Conferences
RSS

Aviptadil does not improve pulmonary vascular resistance in phase II trial in PAH

Sep. 20, 2010

Researchers describe new mPTP inhibitors

Sep. 20, 2010

Domain Therapeutics describes new adenosine A2A and A3 receptor antagonists

Sep. 17, 2010

DHEAS levels in plasma identified as putative biomarker for fibromyalgia

Sep. 17, 2010

Almirall describes pre-candidate agents for multiple sclerosis

Sep. 17, 2010

Enoxaparin yields superior net clinical benefit to UFH in subjects undergoing PCI for STEMI

Sep. 17, 2010

Lundbeck and Argenta disclose promising preclinical data on MCH1 receptor antagonists

Sep. 17, 2010

RAAM-DHF trial finds eplerenone may benefit patients with diastolic heart failure

Sep. 17, 2010

PAF-R is potential target to treat psoriasis

Sep. 17, 2010

GSK presents new prostanoid DP1 receptor antagonists

Sep. 16, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...